PRAXPraxis Precision Medicines, Inc.

PRAX Stock Price, Valuation & Chart | Praxis Precision Medicines, Inc.

Compare

$353.44+3.14 (+0.90%)

At close · 01 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology PRAX intrinsic value PRAX calculated fair value vs price

Overview Financials Dividends Ratios

PRAX Historical price chart

PRAX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization9.85B

PE Ratio-27.33

EPS-12.93

Trading Volume305.81K

Today's High/Low355.49/347.96

Dividend Yield0.00

52 Week High/Low392.7/37.19

Shares Outstanding27.88M

PRAX Financial Statement

PRAX Analyst ratings

PRAX Analysis & performance metrics

PRAX Company profile

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its…

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and…

PRAX Management team

Name

Position

Timothy Edwin KellyCFO

Chief Financial Officer & Treasurer

Marcio Silva De'Souza M.B.A.CEO

President, Chief Executive Officer & Director

Lauren Mastrocola

Vice President of Finance & Principal Accounting Officer

Megan T. Sniecinski

Chief Business Officer

Alyssa J. S. Wyant

Chief Regulatory & Quality Officer

Steven Petrou B.Sc. (Hons.), Ph.D.

Co-Founder & Chief Scientific Officer

Alex Kane

Vice President of Investor Relations & Corporate Communications

Alex Nemiroff J.D.

General Counsel & Secretary

Name

Position

Timothy Edwin KellyCFO

Chief Financial Officer & Treasurer

Marcio Silva De'Souza M.B.A.CEO

President, Chief Executive Officer & Director

Lauren Mastrocola

Vice President of Finance & Principal Accounting Officer

Megan T. Sniecinski

Chief Business Officer

Alyssa J. S. Wyant

Chief Regulatory & Quality Officer

Steven Petrou B.Sc. (Hons.), Ph.D.

Co-Founder & Chief Scientific Officer

Alex Kane

Vice President of Investor Relations & Corporate Communications

Alex Nemiroff J.D.

General Counsel & Secretary

Management Team

Timothy Edwin KellyCFO

Chief Financial Officer & Treasurer

Marcio Silva De'Souza M.B.A.CEO

President, Chief Executive Officer & Director

Lauren Mastrocola

Vice President of Finance & Principal Accounting Officer

Megan T. Sniecinski

Chief Business Officer

Alyssa J. S. Wyant

Chief Regulatory & Quality Officer

Steven Petrou B.Sc. (Hons.), Ph.D.

Co-Founder & Chief Scientific Officer

Alex Kane

Vice President of Investor Relations & Corporate Communications

Alex Nemiroff J.D.

General Counsel & Secretary

Management

Timothy Edwin KellyCFO

Chief Financial Officer & Treasurer

Marcio Silva De'Souza M.B.A.CEO

President, Chief Executive Officer & Director

Lauren Mastrocola

Vice President of Finance & Principal Accounting Officer

Megan T. Sniecinski

Chief Business Officer

Alyssa J. S. Wyant

Chief Regulatory & Quality Officer

Steven Petrou B.Sc. (Hons.), Ph.D.

Co-Founder & Chief Scientific Officer

Alex Kane

Vice President of Investor Relations & Corporate Communications

Alex Nemiroff J.D.

General Counsel & Secretary

Total 8 executives

PRAX Frequently asked questions

What is Praxis Precision Medicines, Inc. (PRAX) Stock Price?

Current stock price of Praxis Precision Medicines, Inc. (PRAX) stock is $353.44. The stock price is +0.90% higher in the session. The intraday range can be seen from this page. Volume of Praxis Precision Medicines, Inc. (PRAX) stock is 305.81K.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Praxis Precision Medicines, Inc. (PRAX) stock price going up or down today?

The stock price of Praxis Precision Medicines, Inc. (PRAX) can change with earnings, company news, and overall market sentiment. Praxis Precision Medicines, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Praxis Precision Medicines, Inc. stock expensive at its current price?

Whether Praxis Precision Medicines, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PRAX on this page is -27.33. EPS on this page is -12.93. Compare those figures with peers and growth expectations before deciding if the current Praxis Precision Medicines, Inc. price is justified.

How has the stock price of Praxis Precision Medicines, Inc. (PRAX) performed historically?

Historical performance for Praxis Precision Medicines, Inc. (PRAX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PRAX reacted to past earnings and market events.

Should I buy Praxis Precision Medicines, Inc. (PRAX) stock, at this price?

Buying Praxis Precision Medicines, Inc. (PRAX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.